COVID-19 has been reported to cause lung fibrosis in some people, but the type of fibrosis that develops is distinct…
Articles by Marisa Wexler, MS
Engineered models of the lung and trachea replicate the cellular dynamics found in living organisms better than other models used…
Ofev (nintedanib) limits the decline in lung function in people with idiopathic pulmonary fibrosis (IPF), regardless of the…
Inhaling secretions produced by lung stem cells could be therapeutically beneficial for those with idiopathic pulmonary fibrosis (IPF), a…
ART-123 (thrombomodulin alfa) failed to prolong the survival of patients with idiopathic pulmonary fibrosis (IPF) who have…
Hepion Pharmaceuticals‘ CRV431 lowers the production of fibrosis-associated proteins in a variety of cell types, including lung cells,…
A new technique to create lung cells from other, more easily accessible cell types could be useful for understanding diseases…
Galapagos NVÂ announced that its Phase 2 PINTA trial, evaluating the safety and effectiveness of oral GLPG1205 in…
Use of INOpulse — inhaled nitric oxide — increased physical activity and improved patient-reported outcomes in people with…
The molecular clockwork that regulates circadian rhythms can become dysregulated in the lungs of people with pulmonary fibrosis, promoting processes…